Skip to main content
Fig. 3 | Molecular Medicine

Fig. 3

From: Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinoma

Fig. 3

Vanoxerine dihydrochloride treatment induced cell apoptosis. Vanoxerine dihydrochloride treatment at at 3, 10, 30μMconcentration for 6, 12, 24 h significantly increased the percentage of apoptosis in a QGY7703 and b Huh7 cell lines in a dose-and time-dependent manner. *p < 0.05, significantly different from the control PBS treatment group

Back to article page